🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. Tranexamic Acid 1000 mg/10ml normal saline infusion

    United Therapeutics Europe Ltd

    Postpartum Hemorrhage

    approved small molecule terminated

    1 trial

  2. Trangorex 200 mg comprimidos

    The George Institute

    Atrial fibrillation

    approved small molecule active

    1 trial

  3. Transanal irrigation with Peristeen Anal Irrigation

    Stoke Therapeutics

    Constipation

    approved other completed

    1 trial

  4. Transdermal Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule terminated

    1 trial

  5. Transdermal nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  6. Transepicardial with Transseptal CD 133+ Implantation

    Hospital Authority, Hong Kong

    Coronary Artery Disease

    approved mab completed

    1 trial

  7. Transmucosal Buprenorphine

    Indivior Pty Ltd

    Moderate to Severe Opioid-use Disorder

    approved small molecule completed

    1 trial

  8. Treatment group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    approved small molecule completed

    1 trial

  9. Treprostinil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    3 trials

  10. Trimebutine 100 MG

    Hospital Authority, Hong Kong

    Helicobacter Pylori Infection

    approved small molecule completed

    1 trial

  11. Triple combination therapy group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  12. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial

  13. Typhoid Vi vaccine

    International Peace Maternity and Child Health Hospital

    Typhoid

    approved mab completed

    1 trial

  14. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    Disc Medicine

    Paroxysmal nocturnal hemoglobinuria (PNH)

    approved small molecule active

    1 trial

  15. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    The George Institute

    IgA nephropathy

    approved small molecule active

    1 trial

  16. Urapidil Accord 5 mg/ml solución inyectable y para perfusión EFG, Trandate 5mg/ml Solution for Injection, Fenilefrina Altan 0,1 mg/ml solución inyectable y para perfusión.

    The George Institute

    Acute Ischemic Stroke

    approved small molecule active

    1 trial

  17. Use of Mitomycin-C (MMC) in trabeculectomy

    AEON Biopharma

    Glaucoma

    approved small molecule completed

    1 trial

  18. VENDY

    Summit Therapeutics

    Harm Reduction

    approved other active

    1 trial

  19. VERAPAMIL , NEBIVOLOL , PROPAFENONE , BISOPROLOL , AMIODARONE , FLECAINIDE , SOTALOL , DILTIAZEM

    Pari Pharma GmbH

    Asymptomatic Patients with frequent PVCs and normal LVEF

    approved small molecule active

    1 trial

  20. VYEPTI 100 mg concentrate for solution for infusion

    H. Lundbeck A/S

    Chronic Migrane, Migrane, Medication Overuse Headache

    approved small molecule active

    1 trial

  21. Vabysmo 120 mg/mL solution for injection

    Hoffmann-La Roche

    Neovascular Age-Related Macular Degeneration

    approved small molecule active

    1 trial

  22. Vabysmo 120 mg/mL solution for injection in pre-filled syringe

    The George Institute

    SUBRETINAL HYPERREFLECTIVE MATERIAL

    approved small molecule active

    1 trial

  23. Vaccination to prevent hepatitis B virus infection

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B

    approved mab completed

    1 trial

  24. Valbenazine

    NEUROCRINE BIOSCIENCES INC

    Tardive Dyskinesia (TD)

    approved small molecule completed

    2 trials

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources